Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants
Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants: A Prospective Medium Term Study
Aula Dental Avanzada
150 participants
Jul 29, 2022
OBSERVATIONAL
Conditions
Summary
The DS Prime Taper EV dental implant system was recently launched on the implant market by Dentsply Sirona (York, PA, USA). Dental implant systems are undergoing rapid evolution, ultimately driven by their broad therapeutic indications. As manufacturers strive to keep up with the demands of a growing market, designs are changing faster than clinical evaluation. This means that the time needed to assess medium- and long-term clinical outcomes before designs change again cannot be met. Clinicians need to have a "real" analysis of the clinical performance of implants before using them. Therefore, reporting of results is necessary to avoid use in patients without proper practical checks even before the recommended 10- and 15-year follow-up periods.
Eligibility
Inclusion Criteria1
- All the patients whom received at least one DS Prime Taper implant.
Exclusion Criteria1
- When dental implant surgery is contraindicated.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Surgical placement of a DS Prime Taper implant and its posterior prosthesis.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05500755